- Home
- PNNT vs ARCT Comparison
PNNT vs ARCT Comparison
Compare PNNT & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNNT
- ARCT
- Stock Information
- Founded
- PNNT 2007
- ARCT 2013
- Country
- PNNT United States
- ARCT United States
- Employees
- PNNT N/A
- ARCT N/A
- Industry
- PNNT Finance: Consumer Services
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- PNNT Finance
- ARCT Health Care
- Exchange
- PNNT Nasdaq
- ARCT Nasdaq
- Market Cap
- PNNT 462.3M
- ARCT 444.5M
- IPO Year
- PNNT 2007
- ARCT N/A
- Fundamental
- Price
- PNNT $7.08
- ARCT $9.43
- Analyst Decision
- PNNT Hold
- ARCT Strong Buy
- Analyst Count
- PNNT 2
- ARCT 7
- Target Price
- PNNT $6.00
- ARCT $57.80
- AVG Volume (30 Days)
- PNNT 431.1K
- ARCT 394.6K
- Earning Date
- PNNT 05-07-2025
- ARCT 03-06-2025
- Dividend Yield
- PNNT 13.29%
- ARCT N/A
- EPS Growth
- PNNT 11.30
- ARCT N/A
- EPS
- PNNT 0.83
- ARCT N/A
- Revenue
- PNNT $143,689,000.00
- ARCT $152,310,000.00
- Revenue This Year
- PNNT N/A
- ARCT N/A
- Revenue Next Year
- PNNT N/A
- ARCT $39.21
- P/E Ratio
- PNNT $8.45
- ARCT N/A
- Revenue Growth
- PNNT N/A
- ARCT N/A
- 52 Week Low
- PNNT $6.43
- ARCT $9.41
- 52 Week High
- PNNT $8.04
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- PNNT 48.15
- ARCT 22.40
- Support Level
- PNNT $6.97
- ARCT $11.71
- Resistance Level
- PNNT $7.23
- ARCT $13.41
- Average True Range (ATR)
- PNNT 0.08
- ARCT 0.86
- MACD
- PNNT -0.00
- ARCT -0.30
- Stochastic Oscillator
- PNNT 55.71
- ARCT 0.39
About PNNT PennantPark Investment Corporation
Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.